Sign In
Buy AXSM
$212.17
+1.13 (+0.535%)
At Close: Aug 04, 2026
Los Angeles, California--(Newsfile Corp. - August 10, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Ax
LOS ANGELES--(BUSINESS WIRE)---- $AXSM #AXSM--INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Axsome Therapeutics, Inc.
NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Axsome Therapeutics, Inc. (NAS
Axsome Therapeutics, Inc. (AXSM) CEO Herriot Tabuteau on Q2 2021 Results - Earnings Call Transcript
11:18am, Monday, 09'th Aug 2021
Axsome Therapeutics, Inc. (AXSM) CEO Herriot Tabuteau on Q2 2021 Results - Earnings Call Transcript
Axsome Stock Drops To 52-Week Low On FDA Response Letter For Depression Candidate
11:02am, Monday, 09'th Aug 2021
Wrapped up in its Q2 earnings release, Axsome Therapeutics Inc (NASDAQ: AXSM) said that on July 30, it received an FDA letter for a marketing application for AXS-05 for the treatment of major depre
Axsome Therapeutics (AXSM) Sees Hammer Chart Pattern: Time to Buy?
09:19am, Monday, 09'th Aug 2021
Axsome Therapeutics (AXSM) has been struggling lately, but the selling pressure may be coming to an end soon.
Axsome Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update
07:05am, Monday, 09'th Aug 2021
Company to host conference call today at 8:00 AM Eastern
Is There Any Hope Left for Axsome Therapeutics?
06:21am, Friday, 30'th Jul 2021
After a fantastic run-up, investors are now losing faith in this emerging biotech's stock.
Will Axsome Stock Rebound After A 19% Fall In A Month?
08:00am, Friday, 23'rd Jul 2021
The stock price of Axsome Therapeutics, a biopharmaceutical company focused on developing novel therapies for central nervous system conditions, has seen a 19% drop over the last twenty-one trading da
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axsome Therapeutics, Inc. - AXSM
10:40am, Sunday, 18'th Jul 2021
NEW YORK, July 18, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Axsome Therapeutics, Inc. ("Axsome" or the "Company") (NASDAQ: AXSM). Such investors are ad
Axsome (AXSM) Falls 10% After Losing Breakthrough Therapy Tag
11:35am, Thursday, 15'th Jul 2021
The FDA rescinds Breakthrough Therapy designation for Axsome's (AXSM) pipeline candidate, AXS-12. The company is developing AXS-12 for the potential treatment of cataplexy in narcolepsy patients.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axsome Therapeutics, Inc. - AXSM
10:08pm, Wednesday, 14'th Jul 2021
NEW YORK, July 14, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Axsome Therapeutics, Inc. ("Axsome" or the "Company") (NASDAQ: AXSM). Such investors are a
Why Shares of Axsome Therapeutics Are Falling Today
04:32pm, Wednesday, 14'th Jul 2021
The FDA took back a beneficial designation but management isn't changing its plans.
Buy This Stock Before Everyone Else Does
09:12am, Wednesday, 14'th Jul 2021
This biotech has significant upside left.
What's Next For Axsome Therapeutics Stock After A 13% Rise In A Month?
10:00am, Monday, 21'st Jun 2021
The stock price of Axsome Therapeutics, a biopharmaceutical company focused on developing novel therapies for central nervous system conditions, has seen a 13% rise over the last twenty-one trading se
